Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine + Rituximab in R/R MCL
NCT00891839Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jun 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bendamustine in mantle cell lymphoma (MCL), sponsored by Cephalon, Inc.. Started Jun 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00891839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891839.